soul trial oral semaglutide cardiovascular outcomes 2024 results mace (Semaglutide triaL) in individuals with Cardiovascular outcomes trials: a paradigm

Vials are despatched from the UK

Key evidence points: GLP-1 medications do not directly target or break down muscle tissue Lean mass loss occurs as a consequence of the calorie deficit and weight reduction The proportion of lean mass lost is comparable to other weight loss methods Greater absolute lean mass loss reflects the greater total weight loss achieved Regulatory bodies including NICE and the MHRA have not identified muscle loss as a specific adverse effect requiring special warnings in the Summary of Product Characteristics (SmPCs), though healthcare professionals are advised to monitor nutritional status and encourage appropriate dietary protein intake and physical activity in patients using these medications for weight management

M.SchellevisF.VerheijT

Experimental literature often explores glutathiones relationship to cytokine signaling , cellular stress responses, and immune-cell functionparticularly in contexts where oxidative stress and inflammation intersect (metabolic strain, toxin exposure, high training loads, or aging-related oxidative burden)

doi: 10.1002/oby.23930

Can men use glutathione